Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **Immunoglobulin superfamily containing leucine-rich repeat protein (ISLR)** is a 428-amino acid extracellular and membrane-associated protein that combines immunoglobulin-like (IgSF) domains with multiple leucine-rich repeat (LRR) motifs. The protein is highly expressed in mesenchymal stromal/stem cells, brown adipose tissue, skeletal muscle, and multiple other tissues including retina, heart, ovary, and testis. ISLR functions in cell adhesion, signaling within the extracellular matrix, and regulation of mitochondrial activity and energy homeostasis. Mechanistically, ISLR interacts with Ndufs2 to modulate IL-6 signaling, acting as a brake to prevent excess brown fat activation following muscle injury, thereby affecting whole-body energy expenditure and thermogenesis. Because of its regulatory role in muscle-adipose tissue communication and metabolic function, ISLR represents a promising novel target for metabolic disease therapeutics, although direct pharmacological targeting has not yet reached clinical application. Additionally, ISLR may serve as a marker for specific stem cell populations and is involved in developmental processes.
Modulates IL-6 signaling by interacting with NADH:Ubiquinone oxidoreductase core subunit S2 (Ndufs2)\nActs as a brake on muscle-derived IL-6, limiting brown adipose tissue activation and thermogenesis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin superfamily containing leucine-rich repeat protein (ISLR).